Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $704.62 | 33 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $362.88 | 17 | $0 (2024) |
| Boston Scientific Corporation | $150.98 | 7 | $0 (2024) |
| Abbott Laboratories | $87.07 | 3 | $0 (2024) |
| Daiichi Sankyo Inc. | $24.21 | 1 | $0 (2017) |
| Nevro Corp. | $18.67 | 1 | $0 (2021) |
| Scilex Pharmaceuticals Inc. | $18.06 | 1 | $0 (2019) |
| Smith+Nephew, Inc. | $15.68 | 1 | $0 (2022) |
| Shionogi Inc | $13.88 | 1 | $0 (2019) |
| Lilly USA, LLC | $13.19 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $280.87 | 12 | ABBVIE INC. ($180.68) |
| 2023 | $190.49 | 9 | ABBVIE INC. ($165.65) |
| 2022 | $69.33 | 4 | Boston Scientific Corporation ($37.10) |
| 2021 | $76.81 | 3 | Abbott Laboratories ($37.51) |
| 2019 | $49.72 | 3 | Scilex Pharmaceuticals Inc. ($18.06) |
| 2017 | $37.40 | 2 | Daiichi Sankyo Inc. ($24.21) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Neuromodulation | ||||||
| 12/19/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/10/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.87 | General |
| Category: NEUROSCIENCE | ||||||
| 10/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $33.68 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.57 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: NEUROSCIENCE | ||||||
| 02/20/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.31 | General |
| Category: NEUROSCIENCE | ||||||
| 02/08/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 02/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: NEUROSCIENCE | ||||||
| 01/25/2024 | Boston Scientific Corporation | Intracept (Device) | Food and Beverage | Cash or cash equivalent | $34.21 | General |
| Category: Pain | ||||||
| 12/11/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: NEUROSCIENCE | ||||||
| 11/28/2023 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Neuromodulation | ||||||
| 11/23/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $31.93 | General |
| Category: NEUROSCIENCE | ||||||
| 10/30/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/08/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: NEUROSCIENCE | ||||||
| 09/02/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.58 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 06/21/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: NEUROSCIENCE | ||||||
| 05/19/2023 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: NEUROSCIENCE | ||||||
| 04/06/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: NEUROSCIENCE | ||||||
| 11/24/2022 | Boston Scientific Corporation | Superion Indirect Decompression System (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Vertiflex Superion_NMD | ||||||
| 09/07/2022 | Boston Scientific Corporation | Superion Indirect Decompression System (Device) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Vertiflex Superion_NMD | ||||||
| 08/18/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: NEUROSCIENCE | ||||||
| 05/20/2022 | Smith+Nephew, Inc. | Pico 14 (Device), PICO 7, RENASYS GO v2 HOME | Food and Beverage | In-kind items and services | $15.68 | General |
| Category: Negative Pressure Wound Therapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 975 | 1,847 | $615,557 | $102,229 |
| 2022 | 22 | 1,093 | 2,171 | $691,677 | $115,682 |
| 2021 | 24 | 1,395 | 2,791 | $873,559 | $148,860 |
| 2020 | 24 | 1,109 | 2,153 | $661,442 | $108,882 |
All Medicare Procedures & Services
92 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 198 | 406 | $75,480 | $26,811 | 35.5% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Facility | 2023 | 40 | 40 | $50,000 | $8,828 | 17.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 97 | 97 | $29,747 | $7,791 | 26.2% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Facility | 2023 | 42 | 74 | $81,400 | $7,534 | 9.3% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 38 | 395 | $26,860 | $7,275 | 27.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 75 | 76 | $18,352 | $7,192 | 39.2% |
| 62323 | Injection of substance into lower spine canal using imaging guidance | Facility | 2023 | 71 | 90 | $71,550 | $6,716 | 9.4% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2023 | 58 | 72 | $79,200 | $6,487 | 8.2% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Facility | 2023 | 38 | 65 | $38,675 | $3,760 | 9.7% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 88 | 89 | $12,282 | $2,852 | 23.2% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Facility | 2023 | 37 | 37 | $18,685 | $2,493 | 13.3% |
| 72148 | Mri scan of lower spinal canal without contrast | Office | 2023 | 25 | 25 | $38,625 | $2,432 | 6.3% |
| 97140 | Therapy procedure using manual technique, each 15 minutes | Office | 2023 | 17 | 124 | $6,820 | $2,210 | 32.4% |
| 97530 | Therapy procedure using functional activities | Office | 2023 | 17 | 84 | $3,612 | $2,020 | 55.9% |
| 97162 | Evaluation for physical therapy, typically 30 minutes | Office | 2023 | 26 | 26 | $6,500 | $1,818 | 28.0% |
| 64479 | Injection of anesthetic and/or steroid drug into upper or middle spine nerve root using imaging guidance, single level | Facility | 2023 | 14 | 16 | $17,600 | $1,509 | 8.6% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 24 | $15,600 | $1,226 | 7.9% |
| 97161 | Evaluation for physical therapy, typically 20 minutes | Office | 2023 | 15 | 15 | $3,000 | $1,193 | 39.8% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Facility | 2023 | 12 | 17 | $13,515 | $692.07 | 5.1% |
| 72040 | X-ray of upper spine, 2-3 views | Office | 2023 | 27 | 27 | $3,375 | $619.59 | 18.4% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 11 | 12 | $3,300 | $470.35 | 14.3% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 18 | 36 | $1,379 | $298.50 | 21.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 217 | 442 | $81,770 | $30,156 | 36.9% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2022 | 60 | 677 | $46,036 | $13,947 | 30.3% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Facility | 2022 | 88 | 108 | $118,800 | $10,074 | 8.5% |
About Dr. Thomas Frates, MD
Dr. Thomas Frates, MD is a Physical Medicine & Rehabilitation healthcare provider based in Bedford, New Hampshire. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1346226578.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Frates, MD has received a total of $704.62 in payments from pharmaceutical and medical device companies, with $280.87 received in 2024. These payments were reported across 33 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($704.62).
As a Medicare-enrolled provider, Frates has provided services to 4,572 Medicare beneficiaries, totaling 8,962 services with total Medicare billing of $475,653. Data is available for 4 years (2020–2023), covering 92 distinct procedure/service records.
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Bedford, NH
- Active Since 12/20/2005
- Last Updated 01/04/2012
- Taxonomy Code 208100000X
- Entity Type Individual
- NPI Number 1346226578
Products in Payments
- UBRELVY (Drug) $191.29
- QULIPTA (Drug) $137.01
- PROCLAIM (Device) $49.56
- WaveWriter Alpha Prime 16 (Device) $41.26
- Proclaim IPG (Device) $37.51
- Superion Indirect Decompression System (Device) $37.10
- BOTOX (Biological) $34.58
- Intracept (Device) $34.21
- Morphabond ER (Drug) $24.21
- GENERAL PAIN MANAGEMENT (Device) $20.63
- Omnia (Device) $18.67
- ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH (Drug) $18.06
- INFINION (Device) $17.78
- Pico 14 (Device) $15.68
- Symproic (Drug) $13.88
- FORTEO (Drug) $13.19
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physical Medicine & Rehabilitation Doctors in Bedford
Dr. Kathleen Leahy, Do, DO
Physical Medicine & Rehabilitation — Payments: $419.41
Dr. Adam Cugalj, D.o, D.O
Physical Medicine & Rehabilitation — Payments: $396.84
Prathusha Maduri
Physical Medicine & Rehabilitation — Payments: $161.47
Dr. Eric Coligado, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $61.99
Dr. Robert Monighetti, M.d, M.D
Physical Medicine & Rehabilitation — Payments: $32.71
Laura Chamberlain, Dpt, DPT
Physical Medicine & Rehabilitation — Payments: $13.86